J
Jerker Jonsson
Researcher at Public Health Agency of Sweden
Publications - 37
Citations - 1183
Jerker Jonsson is an academic researcher from Public Health Agency of Sweden. The author has contributed to research in topics: Tuberculosis & Population. The author has an hindex of 13, co-authored 35 publications receiving 803 citations. Previous affiliations of Jerker Jonsson include Karolinska Institutet & Karolinska University Hospital.
Papers
More filters
Journal ArticleDOI
Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study
Sergey Borisov,Keertan Dheda,Martin Enwerem,Rodolfo Romero Leyet,Lia D'Ambrosio,Rosella Centis,Giovanni Sotgiu,Simon Tiberi,Simon Tiberi,Jan-Willem C. Alffenaar,Andrey Maryandyshev,Evgeny Belilovski,Shashank Ganatra,Alena Skrahina,Onno W. Akkerman,Alena Aleksa,Rohit Amale,Janina Artsukevich,Judith Bruchfeld,Jose A. Caminero,Isabel Carpena Martinez,Luigi Codecasa,Margareth Pretti Dalcolmo,Justin T Denholm,Paul Douglas,Raquel Duarte,Aliasgar Esmail,Mohammed Fadul,Alexey Filippov,Lina Davies Forsman,Mina Gaga,Julia Amaranta Garcia-Fuertes,José-María García-García,Gina Gualano,Jerker Jonsson,Heinke Kunst,Jillian S.Y. Lau,Barbara Lazaro Mastrapa,Jorge Lazaro Teran Troya,Selene Manga,Katerina Manika,Pablo González Montaner,Jai B Mullerpattan,Suzette Oelofse,Martina Ortelli,Domingo Palmero,Fabrizio Palmieri,Antonella Papalia,Apostolos Papavasileiou,Marie-Christine Payen,Emanuele Pontali,Carlos Robalo Cordeiro,Laura Saderi,Tsetan Dorji Sadutshang,Tatsiana Sanukevich,Varvara Solodovnikova,Antonio Spanevello,Sonam Topgyal,Federica Toscanini,Adrian R Tramontana,Zarir F Udwadia,Pietro Viggiani,Veronica White,Alimuddin Zumla,Giovanni Battista Migliori +64 more
TL;DR: Bedaquiline-containing regimens achieved high conversion and success rates under different nonexperimental conditions, and is safe and effective in treating MDR- and XDR-TB patients.
Journal ArticleDOI
Challenges in diagnosing extrapulmonary tuberculosis in the European Union, 2011.
Ivan Solovic,Jerker Jonsson,Maria Korzeniewska-Kosela,D. I. Chiotan,A. Pace-Asciak,E. Slump,R Rumetshofer,Ibrahim Abubakar,S. Kos,P. Svetina-Sorli,Walter Haas,T Bauer,Andreas Sandgren,M J van der Werf +13 more
TL;DR: In the European Union (EU) 72,334 tuberculosis (TB) cases were notified in 2011, of which 16,116 (22%) had extrapulmonary tuberculosis (EPTB).
Journal ArticleDOI
Association of Maternal SARS-CoV-2 Infection in Pregnancy With Neonatal Outcomes.
Mikael Norman,Mikael Norman,Lars Navér,Lars Navér,Jonas Söderling,Mia Ahlberg,Mia Ahlberg,Helena H. Askling,Bernice Aronsson,Emma Byström,Jerker Jonsson,Verena Sengpiel,Verena Sengpiel,Jonas F. Ludvigsson,Jonas F. Ludvigsson,Stellan Håkansson,Olof Stephansson,Olof Stephansson +17 more
TL;DR: In this paper, the authors evaluated neonatal outcomes in relation to maternal SARS-CoV-2 test positivity in pregnancy and found that positive pregnancy infection was associated with small increases in some neonatal morbidities.
Journal ArticleDOI
Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report
Sergey Borisov,Edvardas Danila,Andrei Maryandyshev,Margareth Pretti Dalcolmo,Skaidrius Miliauskas,Liga Kuksa,Selene Manga,Alena Skrahina,Saulius Diktanas,Luigi Codecasa,Alena Aleksa,Judith Bruchfeld,Judith Bruchfeld,Antoniya Koleva,Alberto Piubello,Zarir F Udwadia,Onno W. Akkerman,Evgeny Belilovski,Enrique Bernal,Martin J. Boeree,Julen Cadiñanos Loidi,Qingshan Cai,Jose Joaquin Cebrian Gallardo,Masoud Dara,Edita Davidavičienė,Lina Davies Forsman,Lina Davies Forsman,Jorge De Los Rios,Justin T Denholm,Jacinta Drakšienė,Raquel Duarte,Seifeldin Eltaeb Elamin,Nadia Escobar Salinas,Maurizio Ferrarese,Alexey Filippov,Ana Garcia,José-María García-García,Ieva Gaudiesiute,Blagovesta Gavazova,Regina Gayoso,R. Rosso,Vygantas Gruslys,Gina Gualano,Wouter Hoefsloot,Jerker Jonsson,Elena Khimova,Heinke Kunst,Rafael Laniado-Laborín,Yang Li,Cecile Magis-Escurra,Vinicio Manfrin,Valentina Marchese,Elena Martínez Robles,Alberto Matteelli,Jesica Mazza-Stalder,Charalampos Moschos,Marcela Muñoz-Torrico,Hamdan Mustafa Hamdan,Birutė Nakčerienė,Laurent P. Nicod,Magnolia Nieto Marcos,Domingo Palmero,Fabrizio Palmieri,Apostolos Papavasileiou,Marie-Christine Payen,Agostina Pontarelli,Sarai Quirós,Adrian Rendon,Laura Saderi,Agnese Šmite,Ivan Solovic,Mahamadou Bassirou Souleymane,Marina Tadolini,Martin van den Boom,Marisa Vescovo,Pietro Viggiani,Askar Yedilbayev,Rolandas Zablockis,Dmitry Zhurkin,Matteo Zignol,Dina Visca,Antonio Spanevello,Jose A. Caminero,Jan-Willem C. Alffenaar,Simon Tiberi,Simon Tiberi,Rosella Centis,Lia D'Ambrosio,Emanuele Pontali,Giovanni Sotgiu,Giovanni Battista Migliori +90 more
TL;DR: This global project (658 patients from 26 countries) demonstrates aDSM is feasible and serious adverse events of recommended drugs are reasonably low (overall 57 out of 504, 11.3%), but implementation needs scaling up to support patient-centred care.
Journal ArticleDOI
Are patients with rheumatoid arthritis still at an increased risk of tuberculosis and what is the role of biological treatments
Elizabeth V. Arkema,Jerker Jonsson,Jerker Jonsson,Eva Baecklund,Judith Bruchfeld,Nils Feltelius,Nils Feltelius,Johan Askling +7 more
TL;DR: In this article, the authors estimate the risk of tuberculosis in patients with rheumatoid arthritis both with and without exposure to biological therapy and directly compare the risks between the two groups.